Showing results (391-400 of 426) with videos related to
Sort By:
Pageof 43
Lancet (London, England)|April 5, 2022
Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trialJustin A Ezekowitz, Eloisa Colin-Ramirez, Heather Ross, et al.The American Journal of Cardiology|April 26, 2016
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)Marco Metra, Robert J Mentz, Adrian F Hernandez, et al.JACC. Heart Failure|November 29, 2020
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF StudyG Michael Felker, John J V McMurray, John G Cleland, et al.European Journal of Heart Failure|May 16, 2018
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetesAbhinav Sharma, Sana M Al-Khatib, Justin A Ezekowitz, et al.Journal of the American College of Cardiology|September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and HyperkalemiaBertram Pitt, Stefan D Anker, Lars H Lund, et al.Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.Journal of Cardiac Failure|February 4, 2012
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline CommitteeWilliam G Stevenson, Adrian F Hernandez, Peter E Carson, et al.BMC Cardiovascular Disorders|July 27, 2014
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) studyJustin A Ezekowitz, Harald Becher, Israel Belenkie, et al.Circulation|September 8, 2023
Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection FractionJesse D Cochran, Yoshimitsu Yura, Mark C Thel, et al.European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.Pageof 43